Biotest
BIO.F
$65.04
Share price
0.48%
Change (1 day)
7.06%
Change (1 year)
Categories
Revenue for Biotest (BIO.F)
Revenue in 2024 (TTM): C$1.04 Billion
According to Biotest
's latest financial reports the company's current revenue (TTM 
) is C$1.08 Billion. In 2023 the company made a revenue of C$0.98 Billion an increase over the revenue in the year 2022 that were of C$0.73 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotest from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | C$1.04 B | 6.01% |
| 2023 | C$0.98 B | 32.94% |
| 2022 | C$0.73 B | -3.23% |
| 2021 | C$0.76 B | 6.53% |
| 2020 | C$0.71 B | 17.06% |
| 2019 | C$0.61 B | -4.36% |
| 2018 | C$0.64 B | 70.36% |
| 2017 | C$0.37 B | -50.63% |
| 2016 | C$0.76 B | -15.69% |
| 2015 | C$0.90 B | 3.02% |
| 2014 | C$0.87 B | 23.75% |
| 2013 | C$0.70 B | 24.45% |
| 2012 | C$0.56 B | -3.76% |
| 2011 | C$0.59 B | 19.6% |
| 2010 | C$0.49 B | -24.06% |
| 2009 | C$0.65 B |